Wellcome Trust’s JPMorgan Chase JPM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,470,000
| Closed | -$278M | – | 25 |
|
|
2022
Q2 | $278M | Hold |
2,470,000
| – | – | 3.63% | 16 |
|
|
2022
Q1 | $337M | Hold |
2,470,000
| – | – | 3.52% | 15 |
|
|
2021
Q4 | $391M | Hold |
2,470,000
| – | – | 3.71% | 15 |
|
|
2021
Q3 | $404M | Hold |
2,470,000
| – | – | 4% | 10 |
|
|
2021
Q2 | $384M | Hold |
2,470,000
| – | – | 3.66% | 10 |
|
|
2021
Q1 | $376M | Sell |
2,470,000
-230,000
| -9% | -$33.1M | 3.92% | 10 |
|
|
2020
Q4 | $343M | Hold |
2,700,000
| – | – | 3.51% | 9 |
|
|
2020
Q3 | $260M | Hold |
2,700,000
| – | – | 3.51% | 13 |
|
|
2020
Q2 | $254M | Sell |
2,700,000
-1,300,000
| -33% | -$123M | 3.86% | 13 |
|
|
2020
Q1 | $360M | Sell |
4,000,000
-700,000
| -15% | -$85M | 6.44% | 5 |
|
|
2019
Q4 | $655M | Hold |
4,700,000
| – | – | 8.77% | 5 |
|
|
2019
Q3 | $553M | Hold |
4,700,000
| – | – | 8.75% | 5 |
|
|
2019
Q2 | $525M | Hold |
4,700,000
| – | – | 8.16% | 5 |
|
|
2019
Q1 | $476M | Hold |
4,700,000
| – | – | 7.7% | 5 |
|
|
2018
Q4 | $459M | Hold |
4,700,000
| – | – | 8.69% | 4 |
|
|
2018
Q3 | $530M | Hold |
4,700,000
| – | – | 8.38% | 5 |
|
|
2018
Q2 | $490M | Hold |
4,700,000
| – | – | 7.85% | 5 |
|
|
2018
Q1 | $517M | Hold |
4,700,000
| – | – | 7.77% | 6 |
|
|
2017
Q4 | $503M | Hold |
4,700,000
| – | – | 7.6% | 6 |
|
|
2017
Q3 | $449M | Hold |
4,700,000
| – | – | 7.17% | 6 |
|
|
2017
Q2 | $430M | Hold |
4,700,000
| – | – | 7.31% | 6 |
|
|
2017
Q1 | $413M | Hold |
4,700,000
| – | – | 7.43% | 5 |
|
|
2016
Q4 | $406M | Hold |
4,700,000
| – | – | 8.11% | 2 |
|
|
2016
Q3 | $313M | Hold |
4,700,000
| – | – | 6.54% | 5 |
|
|
2016
Q2 | $292M | Hold |
4,700,000
| – | – | 6.64% | 3 |
|
|
2016
Q1 | $278M | Hold |
4,700,000
| – | – | 6.16% | 4 |
|
|
2015
Q4 | $310M | Buy |
4,700,000
+100,000
| +2% | +$6.51M | 6.18% | 4 |
|
|
2015
Q3 | $280M | Buy |
4,600,000
+200,000
| +5% | +$13.1M | 6.2% | 3 |
|
|
2015
Q2 | $298M | Buy |
4,400,000
+100,000
| +2% | +$6.53M | 6.03% | 3 |
|
|
2015
Q1 | $260M | Buy |
4,300,000
+50,000
| +1% | +$2.96M | 5.59% | 3 |
|
|
2014
Q4 | $266M | Hold |
4,250,000
| – | – | 5.48% | 5 |
|
|
2014
Q3 | $256M | Buy |
4,250,000
+250,000
| +6% | +$14.6M | 5.31% | 5 |
|
|
2014
Q2 | $230M | Hold |
4,000,000
| – | – | 5.55% | 6 |
|
|
2014
Q1 | $243M | Buy |
4,000,000
+200,000
| +5% | +$11.6M | 5.98% | 5 |
|
|
2013
Q4 | $222M | Hold |
3,800,000
| – | – | 5.89% | 6 |
|
|
2013
Q3 | $196M | Hold |
3,800,000
| – | – | 6.47% | 5 |
|
|
2013
Q2 | $201M | Buy |
+3,800,000
| New | +$193M | 7.1% | 1 |
|
Other funds holding JPM
Wellcome Trust's JPM Position: Q3 2022 in Review
Wellcome Trust sold out of JPMorgan Chase (JPM) in Q3 2022, closing a stake of 2,470,000 shares — an estimated $278M sold.
Wellcome Trust first reported a position in JPM in Q2 2013 and held it in 37 quarters. The position peaked at $655M in Q4 2019. 3,391 funds tracked by Wall St. Rank hold JPM as of Q3 2022.
- Wellcome Trust reported no remaining JPMorgan Chase position as of Q3 2022 after selling out during the quarter.
- Wellcome Trust sold 2,470,000 JPMorgan Chase shares in Q3 2022, an estimated $278M.
- Wellcome Trust first reported a position in JPMorgan Chase in Q2 2013 and held it in 37 quarters.
- Wellcome Trust's JPMorgan Chase position peaked at $655M in Q4 2019.
- 3,391 funds tracked by Wall St. Rank held JPMorgan Chase as of Q3 2022.
Based on Wellcome Trust's 13F filing for Q3 2022, filed 26 Oct 2022.